Ditchcarbon
  • Contact
  1. Organizations
  2. JOINTOWN PHARMACEUTICAL GROUP
Public Profile
Pharmaceutical Preparation Manufacturing
CN
updated 8 days ago

JOINTOWN PHARMACEUTICAL GROUP

Company website

JOINTOWN PHARMACEUTICAL GROUP, a leading player in the pharmaceutical industry, is headquartered in China and operates extensively across various regions. Founded in 1995, the company has established itself as a key provider of high-quality pharmaceutical products and services, focusing on areas such as drug distribution, manufacturing, and research and development. With a diverse portfolio that includes prescription medications, over-the-counter products, and healthcare services, JOINTOWN is recognised for its commitment to innovation and quality. The company has achieved significant milestones, including strategic partnerships and expansions that enhance its market position. JOINTOWN PHARMACEUTICAL GROUP continues to set industry standards, making it a trusted name in healthcare solutions.

DitchCarbon Score

How does JOINTOWN PHARMACEUTICAL GROUP's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

24

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

JOINTOWN PHARMACEUTICAL GROUP's score of 24 is lower than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.

39%

Let us know if this data was useful to you

JOINTOWN PHARMACEUTICAL GROUP's reported carbon emissions

In 2024, JOINTOWN PHARMACEUTICAL GROUP reported total carbon emissions of approximately 36,924,210 kg CO2e for Scope 1 and about 11,005,200 kg CO2e for Scope 2, resulting in a combined total of approximately 47,929,410 kg CO2e. This data reflects the company's commitment to transparency in its emissions reporting. In 2023, the company recorded Scope 1 emissions of approximately 318,939,120 kg CO2e, with specific contributions from mobile combustion (about 2,405,420 kg CO2e) and stationary combustion (approximately 4,334,300 kg CO2e). Notably, JOINTOWN PHARMACEUTICAL GROUP has not disclosed any Scope 3 emissions data. Despite the significant emissions figures, the company has not set specific reduction targets or initiatives, nor does it participate in recognised climate pledges such as the Science Based Targets initiative (SBTi). The absence of reduction targets indicates a potential area for improvement in their climate strategy. JOINTOWN PHARMACEUTICAL GROUP operates independently without cascading emissions data from a parent organisation, ensuring that its reported figures are solely reflective of its own operations.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20232024
Scope 1
318,939,120
00,000,000
Scope 2
-
00,000,000
Scope 3
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. JOINTOWN PHARMACEUTICAL GROUP's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for JOINTOWN PHARMACEUTICAL GROUP is in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

JOINTOWN PHARMACEUTICAL GROUP is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Shanghai Pharmaceuticals

CN
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Wanjia Group Holdings Limited

HK
•
Pharmaceutical Preparation Manufacturing
Updated 15 days ago

China National Accord Medicines Corporation Ltd.

CN
•
Retail trade services, except of motor vehicles and motorcycles; repair services of personal and household goods (52)
Updated 19 days ago

Teva Pharmaceuticals

IL
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

CHINA NATIONAL PHARMACEUTICAL GROUP

CN
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251005.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy